BioNxt Solutions Inc. (FRA:BXT)

Market Cap	42.89M
Revenue (ttm)	14.71K
Net Income (ttm)	-3.68M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,036
Average Volume	20,327
Open	0.3440
Previous Close	0.3280
Day's Range	0.3400 - 0.3670
52-Week Range	0.1200 - 0.4050
Beta	n/a
RSI	53.09
Earnings Date	Jun 2, 2025

About BioNxt Solutions

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was f...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BXT

Financial Performance

In 2023, BioNxt Solutions's revenue was 372,247, an increase of 25.15% compared to the previous year's 297,442. Losses were -7.72 million, -37.60% less than in 2022.

Financial numbers in CAD